Avantor, Inc. (NYSE:AVTR) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC raised its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 7.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,150,788 shares of the company's stock after purchasing an additional 739,667 shares during the quarter. Geode Capital Management LLC owned 1.64% of Avantor worth $287,791,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. increased its stake in Avantor by 2.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company's stock worth $644,000 after buying an additional 503 shares during the period. Intech Investment Management LLC increased its position in shares of Avantor by 1.8% during the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company's stock worth $616,000 after acquiring an additional 514 shares during the period. Arizona State Retirement System raised its stake in shares of Avantor by 0.3% in the second quarter. Arizona State Retirement System now owns 186,567 shares of the company's stock valued at $3,955,000 after acquiring an additional 528 shares in the last quarter. Veracity Capital LLC boosted its holdings in Avantor by 1.0% in the third quarter. Veracity Capital LLC now owns 52,359 shares of the company's stock valued at $1,355,000 after purchasing an additional 543 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its stake in Avantor by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock worth $571,000 after purchasing an additional 733 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of AVTR stock traded down $0.20 during trading hours on Friday, hitting $22.33. The stock had a trading volume of 3,578,948 shares, compared to its average volume of 6,472,614. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The firm has a market capitalization of $15.20 billion, a PE ratio of 48.54, a PEG ratio of 2.75 and a beta of 1.29. The stock's 50 day moving average is $22.47 and its 200 day moving average is $23.53. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of analyst reports. Robert W. Baird reduced their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. UBS Group dropped their price objective on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research report on Tuesday, October 8th. Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. Finally, Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $27.69.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.